← Leaderboards
Kenneth Offit
Columbia University Health Sciences
$5,262,915
Attributed
$9,760,059
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,496,852 · 6
By mechanism
P01$8,415,085 · 2
R01$8,081,767 · 3
U01$0 · 1
Top collaborators
- Steven Monroe Lipkin5 shared
- Fergus Joseph Couch4 shared
- Jada Gabrielle Hamilton4 shared
- Katherine L Nathanson4 shared
- Mark M. Pomerantz4 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Mary Beth Terry$27,685,500
- Edward V Nunes$88,947,598
- Jasmine Alise McDonald$3,763,578
- Regina M Santella$21,752,808
- Wendy K Chung$27,581,365
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesVariantPathogenicityMutationMalignant Neoplasm Of ProstateAffectCessation Of LifePatient CareDna RepairMalignant NeoplasmsHigh RiskAccountingCancer RiskFrequenciesPrevalenceDana-Farber Cancer InstituteCandidate Disease GeneFamily MemberExperimental StudyGeneticGenomeDisorder RiskBrca2 GeneDna Repair Pathway
Grant awards (24)
Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling$844,405
R01 · FY2025 · HG · contact PI
The Impact of DNA Damage Repair Abnormalities in Prostate Cancer$1,617,094
P01 · FY2024 · CA · contact PI
Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling$850,116
R01 · FY2024 · HG · contact PI
The Clinical and Epidemiological Characterization of Pathogenic DNA Damage Repair Pathway Variation in Prostate Cancer$283,897
P01 · FY2024 · CA · contact PI
The Impact of DNA Damage Repair Abnormalities in Prostate Cancer$1,668,159
P01 · FY2023 · CA · contact PI
Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling$876,679
R01 · FY2023 · HG · contact PI
The Clinical and Epidemiological Characterization of Pathogenic DNA Damage Repair Pathway Variation in Prostate Cancer$294,110
P01 · FY2023 · CA · contact PI
The Impact of DNA Damage Repair Abnormalities in Prostate Cancer$1,668,159
P01 · FY2022 · CA · contact PI
Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling$884,999
R01 · FY2022 · HG · contact PI
The Clinical and Epidemiological Characterization of Pathogenic DNA Damage Repair Pathway Variation in Prostate Cancer$294,110
P01 · FY2022 · CA · contact PI
The Impact of DNA Damage Repair Abnormalities in Prostate Cancer$1,783,381
P01 · FY2021 · CA · contact PI
The Clinical and Epidemiological Characterization of Pathogenic DNA Damage Repair Pathway Variation in Prostate Cancer$373,961
P01 · FY2021 · CA · contact PI
The Clinical and Epidemiological Characterization of Pathogenic DNA Damage Repair Pathway Variation in Prostate Cancer$432,214
P01 · FY2019 · CA · contact PI
Identifying and validating novel susceptibility genes for breast cancer$680,501
R01 · FY2017 · CA
Identifying and validating novel susceptibility genes for breast cancer$675,236
R01 · FY2016 · CA
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes$494,158
R01 · FY2016 · CA
Identifying and validating novel susceptibility genes for breast cancer$676,922
R01 · FY2015 · CA
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes$350,675
R01 · FY2015 · CA
Identifying and validating novel susceptibility genes for breast cancer$704,905
R01 · FY2014 · CA
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes$330,593
R01 · FY2014 · CA
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes$320,150
R01 · FY2013 · CA
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes$392,428
R01 · FY2012 · CA
GENETIC MODIFIERS OF BRCA PENETRANCE IN ASHKENAZIM$0
U01 · FY2002 · CA
GENETIC MODIFIERS OF BRCA PENETRANCE IN ASHKENAZIM$0
U01 · FY2001 · CA